Bio Decontamination Market

Bio Decontamination Market by Product (Equipment, Consumables), Agent (Hydrogen Peroxide, Chlorine Dioxide, Nitrogen Dioxide), Type (Room Decontamination, Chamber Decontamination), End User (Hospital & Healthcare facilities) & Region - Global Forecast to 2028

Report Code: MD 7164 Jun, 2023, by marketsandmarkets.com

The global bio decontamination market in terms of revenue was estimated to be worth $238 million in 2023 and is poised to reach $339 million by 2028, growing at a CAGR of 7.3% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of this market is majorly driven by the increased outsourcing of bio decontamination services and Growing healthcare sector and increasing outsourcing in emerging economies. However, Challenges associated with Variability of pathogen resistance may threat the growth of this market.

Attractive Opportunities in the Bio Decontamination Market

Bio Decontamination Market

To know about the assumptions considered for the study, Request for Free Sample Report

Bio Decontamination Market

Recession Impact on the Bio Decontamination Market

The impact of a recession on the market is increased competition. As organizations become more price-sensitive, they may seek bio decontamination providers or technologies at a lower cost, potentially leading to price pressure and decreased profit margins for existing providers.

However, the market may also be somewhat recession-resistant, as certain industries, such as healthcare and pharmaceuticals, may continue to require bio decontamination services regardless of economic conditions. Additionally, as the importance of public health and safety is emphasized during times of crisis, such as a pandemic, there may be increased awareness and demand for bio decontamination services and technologies.

Bio Decontamination Dynamics

DRIVER: Rising growth in pharmaceutical & biotechnology industries

Bio decontamination equipment, services, consumables, and accessories are widely used in pharmaceutical companies, especially in parenteral (injectable) manufacturing. According to the European Federation of Pharmaceutical Industries & Associations (EFPIA), the global pharmaceuticals were USD 1,077,856 in 2020. Furthermore, according to the Pharmaceutical Executive, the top 15 pharmaceutical companies invested USD 133 billion in 2021 in R&D expenditure. With the rising R&D expenditure and the increasing focus on the development of new therapeutic and diagnostic products, the demand for state-of-the-art facilities equipped with modern machines & instruments and a properly decontaminated environment (for efficient & effective research and manufacturing) is expected to increase in the coming years. This is considered a positive indicator for the growth of the market during the forecast period.

OPPORTUNITY: Growing healthcare sector and increasing outsourcing in emerging economies

Emerging markets, such as India and China, are considered cost-saving hubs by developed countries. During the last decade, businesses in developed markets, such as the US and Europe, have outsourced their manufacturing and packaging operations to China, South Korea, Taiwan, and India to leverage the lower labor costs and less-stringent government regulations in these countries. As these countries are becoming major manufacturing hubs, there is a greater focus on quality parameters and the adoption of technologically advanced products to cater to customer requirements. Consequently, the adoption of bio decontamination products & services is growing across many industries in these countries. According to Dezan Shira & Associates (2020), by 2030, China is expected to account for more than 25% of the global medical device industry (at over USD 200 billion) as decontamination is an essential service in medical devices hence the market is anticipated grow. Moreover, setting up and maintaining in-house bio decontamination capabilities may be expensive. Outsourcing allows them to benefit from economies of scale, as service providers can leverage their resources across multiple clients, resulting in potential cost savings for the healthcare facility this will support to thrive the market in emerging economies during the forecast period.

CHALLENGE: Variability of pathogen-resistance

The variability of pathogen challenge is an important consideration in the market. Different pathogens have varying levels of resistance, persistence, and susceptibility to decontamination methods. Here are some key factors that contribute to the variability of pathogen challenge in bio decontamination:

Pathogen Types: Different types of pathogens pose varying challenges in terms of their resistance and susceptibility to decontamination. Bacteria, viruses, fungi, and spores all have different characteristics and responses to disinfectants and decontamination methods. For example, spores such as those produced by Clostridium difficile, or Bacillus anthracis can be particularly resistant and challenging to eliminate.

Pathogen Resistance: Pathogens can develop resistance to disinfectants and antimicrobial agents over time. Factors such as genetic mutations, adaptation, or exposure to sublethal doses of disinfectants can contribute to the development of resistance. Some pathogens may have inherent resistance mechanisms that make them more difficult to eradicate.

Environmental Conditions: Pathogens can exhibit different levels of survival and persistence under varying environmental conditions. Factors such as temperature, humidity, pH, and the presence of organic matter can influence the viability and susceptibility of pathogens to decontamination methods. Some pathogens may survive longer in certain environments, making them more challenging to eliminate.

Surface Contamination: Pathogens can adhere to surfaces and form biofilms, which provide protective barriers and increase their resistance to disinfection. The type of surface, its texture, porosity, and the presence of organic or inorganic matter can affect the ability of disinfectants to reach and eliminate pathogens effectively.

US accounted for the largest share of the North American bio decontamination market in 2022.

Based on the region, the North American market is segmented into US and Canada. In 2022, the US accounted for the largest share of the North American market. Growth in this market can be attributed to presence of stringent regulatory standard, rising healthcare expenditure, rising focus on infection control, the increasing number of surgical procedures performed in the US as Hospitals & healthcare facilities need to be decontaminated, especially in critical areas such as ICUs and operation theatres, the rising geriatric population, presence of majority of key players, and chronic diseases.

China registered the highest growth rate in Asia Pacific bio decontamination market

The APAC market is segmented into Japan, China, India, and Rest of Apac. In 2022, China accounted for the highest growth rate of the Asian market. The high growth rate of China can be attributed to expanding occurrences of HAIs, expansion of pharma, biotech and med tech companies, and alteration of healthcare infrastructure.

Germany in European bio decontamination market to witness the growth rate during the forecast period.

The Europe Market is segmented into Germany, Italy, France, Spain, the UK, and the Rest of Europe. Germany is registered the highest growth rate during the forecast period. The major factors contributing to the growth of this market are the climbing old age population, upsurging incidence infectious diseases, moreover Germany is leading manufacturers of high-quality medical equipment which results high requirement for bio decontamination products and services used by medical device manufacturers.

Bio Decontamination Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Some of the major players operating in this market are Steris (US), Ecolab (US), TOMI Environmental Solutions, Inc (US). In 2022, Ecolab (US), held the leading position in the market. The company has a strong geographic presence across North America, Europe, and Asia Pacific. Steris PLC (US), held the second position in the bio decontamination market in 2022.  

Bio Decontamination Market Report Scope

Report Metric 

Details 

Market Revenue in 2023

$238 million

Projected Revenue by 2028

$339 million

Revenue Rate

Poised to Grow at a CAGR of 7.3%

Market Driver

Rising growth in pharmaceutical & biotechnology industries

Market Opportunity

Growing healthcare sector and increasing outsourcing in emerging economies

This research report categorizes the bio decontamination market to forecast revenue and analyze trends in each of the following submarkets:

By Product & Service

  • Equipment
  • Services
  • Consumables

By Agent Type

  • Hydrogen Peroxide
  • Chlorine Dioxide
  • Peracetic Acid
  • Nitrogen Dioxide

By Type

  • Chamber Decontamination
  • Room Decontamination

By End User

  • Pharmaceutical & Medical Device Manufacturing Companies
  • Life Sciences & Biotechnology Research Organizations
  • Hospitals & Healthcare Facilities

By Region

  • North America
  • Europe
  • Apac
  • RoW

Recent Developments

  • In July 22, Ecolab’s (US) Bioquell HPV-AQ received an authorized approval for use in all territories of the European Union and the European Economic Area.
  • In Dec 2022, the TOMI Environmental Solutions, Inc (US) launched new SteraMist products, which include the Select Plus-a hybrid product consisting of the Company’s current Surface Select and Environment systems. (The system is 24 volts, allowing for universal outlet usage and convert more of the hydrogen peroxide BIT Solution to hydroxyl radicals thus lowering H2O2 PPM levels allowing for faster turnaround time).

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 23)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKET SEGMENTATION
           1.3.2 GEOGRAPHIC SCOPE
           1.3.3 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 STAKEHOLDERS 
    1.6 LIMITATIONS 
    1.7 SUMMARY OF CHANGES 
    1.8 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 27)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                                FIGURE 2 KEY INDUSTRY INSIGHTS
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 BOTTOM-UP APPROACH
                    FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
                    FIGURE 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
                    FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS 
    2.5 STUDY ASSUMPTIONS 
    2.6 GROWTH RATE ASSUMPTIONS 
    2.7 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT ANALYSIS
           2.7.1 SCOPE-RELATED LIMITATIONS
    2.8 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 39)
    FIGURE 9 BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
    FIGURE 10 MARKET, BY AGENT TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET: REGIONAL SNAPSHOT
 
4 PREMIUM INSIGHTS (Page No. - 43)
    4.1 BIO DECONTAMINATION MARKET OVERVIEW 
          FIGURE 14 INCREASING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET
    4.2 NORTH AMERICA: MARKET, BY END USER AND COUNTRY 
          FIGURE 15 PHARMACEUTICAL & MEDICAL DEVICE MANUFACTURING COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
    4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 46)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 17 BIO DECONTAMINATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising incidence of hospital-acquired infections
                    5.2.1.2 Increasing number of surgical procedures
                                TABLE 2 US: PERCENTAGE INCREASE IN SURGERIES PERFORMED
                                TABLE 3 US: NUMBER OF AESTHETIC SURGERIES PERFORMED (2020 VS. 2021)
                    5.2.1.3 Growing outsourcing of bio decontamination services to third-party providers
                    5.2.1.4 Rising growth in pharmaceutical & biotechnology industry
                    5.2.1.5 Stringent regulatory guidelines for pharmaceutical & medical device manufacturing companies
           5.2.2 RESTRAINTS
                    5.2.2.1 Use of manual bio decontamination methods in emerging economies
                    5.2.2.2 Rising adoption of single-use medical devices
                    5.2.2.3 Availability of alternative techniques
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing healthcare sector in emerging markets
                    5.2.3.2 Increasing establishment of pharmaceutical & medical device companies
                    5.2.3.3 Rising adoption of nitrogen dioxide bio decontamination
                    5.2.3.4 Increasing number of hospitals and healthcare facilities
           5.2.4 CHALLENGES
                    5.2.4.1 Challenges associated with equipment & technology costs
                    5.2.4.2 Variability of pathogen resistance
                    5.2.4.3 Safety concerns regarding hazardous chemicals
           5.2.5 TRENDS
                    5.2.5.1 Increasing focus on infection control
                    5.2.5.2 Adoption of eco-friendly decontamination products
    5.3 VALUE CHAIN ANALYSIS 
          FIGURE 18 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASE
    5.4 SUPPLY CHAIN ANALYSIS 
          FIGURE 19 DIRECT DISTRIBUTION-PREFERRED STRATEGY FOR PROMINENT COMPANIES
    5.5 TECHNOLOGY ANALYSIS 
    5.6 PORTER’S FIVE FORCES ANALYSIS 
           5.6.1 THREAT OF NEW ENTRANTS
           5.6.2 INTENSITY OF COMPETITIVE RIVALRY
           5.6.3 BARGAINING POWER OF BUYERS
           5.6.4 BARGAINING POWER OF SUPPLIERS
           5.6.5 THREAT OF SUBSTITUTES
    5.7 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
                    TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 END USERS (%)
           5.7.2 BUYING CRITERIA
                    FIGURE 21 KEY BUYING CRITERIA FOR END USERS
                    TABLE 5 KEY BUYING CRITERIA FOR END USERS
    5.8 REGULATORY LANDSCAPE 
          TABLE 6 INDICATIVE LIST OF REGULATORY AUTHORITIES FOR MARKET
           5.8.1 NORTH AMERICA
           5.8.2 EUROPE
    5.9 PATENT ANALYSIS 
    5.10 KEY CONFERENCES AND EVENTS 
          TABLE 7 LIST OF CONFERENCES AND EVENTS (2023−2024)
    5.11 PRICING ANALYSIS 
          TABLE 8 PRICE RANGE FOR BIO DECONTAMINATION PRODUCTS
    5.12 TRADE ANALYSIS 
          TABLE 9 IMPORT DATA FOR HS CODE 840510, BY COUNTRY, 2018–2022 (USD THOUSAND)
          TABLE 10 EXPORT DATA FOR HS CODE 840510, BY COUNTRY, 2018–2022 (USD THOUSAND)
    5.13 ECOSYSTEM ANALYSIS 
           5.13.1 ROLE IN ECOSYSTEM
           5.13.2 KEY PLAYERS OPERATING IN MARKET
    5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
 
6 BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE (Page No. - 70)
    6.1 INTRODUCTION 
          TABLE 11 MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
    6.2 EQUIPMENT 
           6.2.1 RISING PREFERENCE FOR AUTOMATED EQUIPMENT TO DRIVE MARKET
                    TABLE 12 MARKET FOR EQUIPMENT, BY REGION, 2021–2028 (USD MILLION)
    6.3 SERVICES 
           6.3.1 LOW COST OF SERVICES TO DRIVE MARKET
                    TABLE 13 MARKET FOR SERVICES, BY REGION, 2021–2028 (USD MILLION)
    6.4 CONSUMABLES 
           6.4.1 RECURRING USAGE OF CONSUMABLES TO SUPPORT MARKET GROWTH
                    TABLE 14 MARKET FOR CONSUMABLES, BY REGION, 2021–2028 (USD MILLION)
 
7 BIO DECONTAMINATION MARKET, BY AGENT TYPE (Page No. - 75)
    7.1 INTRODUCTION 
          TABLE 15 MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
    7.2 HYDROGEN PEROXIDE 
           7.2.1 ADVANTAGES OF SAFETY AND HIGH MATERIAL COMPATIBILITY TO DRIVE MARKET
                    TABLE 16 MARKET FOR HYDROGEN PEROXIDE, BY REGION, 2021–2028 (USD MILLION)
    7.3 CHLORINE DIOXIDE 
           7.3.1 EFFECTIVE STERILANT FOR MICROBIOLOGICAL CONTAMINANTS
                    TABLE 17 COMPARISON OF MANUAL DISINFECTION & DECONTAMINATION USING CHLORINE DIOXIDE GAS
                    TABLE 18 MARKET FOR CHLORINE DIOXIDE, BY REGION, 2021–2028 (USD MILLION)
    7.4 PERACETIC ACID 
           7.4.1 UTILIZATION IN AEROSOL SYSTEMS AND CLEANROOMS TO PROPEL MARKET
                    TABLE 19 MARKET FOR PERACETIC ACID, BY REGION, 2021–2028 (USD MILLION)
    7.5 NITROGEN DIOXIDE 
           7.5.1 RAPID & EFFECTIVE DECONTAMINATION AT LOW HUMIDITY LEVELS TO SUPPORT MARKET GROWTH
                    TABLE 20 MARKET FOR NITROGEN DIOXIDE, BY REGION, 2021–2028 (USD MILLION)
 
8 BIO DECONTAMINATION MARKET, BY TYPE (Page No. - 81)
    8.1 INTRODUCTION 
          TABLE 21 MARKET, BY TYPE, 2021–2028 (USD MILLION)
    8.2 CHAMBER DECONTAMINATION 
           8.2.1 LOWER COST AND MINIMAL POWER REQUIREMENTS TO DRIVE MARKET
                    TABLE 22 MARKET FOR CHAMBER DECONTAMINATION, BY REGION, 2021–2028 (USD MILLION)
    8.3 ROOM DECONTAMINATION 
           8.3.1 REQUIREMENT OF HUMAN INTERVENTION TO RESTRAIN MARKET GROWTH
                    TABLE 23 ROOM DECONTAMINATION APPLICATION CATEGORIES (INDICATIVE LIST)
                    TABLE 24 MARKET FOR ROOM DECONTAMINATION, BY REGION, 2021–2028 (USD MILLION)
 
9 BIO DECONTAMINATION MARKET, BY END USER (Page No. - 85)
    9.1 INTRODUCTION 
          TABLE 25 MARKET, BY END USER, 2021–2028 (USD MILLION)
    9.2 PHARMACEUTICAL AND MEDICAL DEVICE MANUFACTURING COMPANIES 
           9.2.1 COMPLIANCE WITH STRINGENT REGULATIONS FOR STERILIZATION OF INSTRUMENTS TO DRIVE MARKET
                    TABLE 26 MARKET FOR PHARMACEUTICAL AND MEDICAL DEVICE MANUFACTURING COMPANIES, BY REGION, 2021–2028 (USD MILLION)
    9.3 LIFE SCIENCES AND BIOTECHNOLOGY RESEARCH ORGANIZATIONS 
           9.3.1 RISING BIOTECHNOLOGY RESEARCH AND UTILIZATION OF DECONTAMINATORS IN CLEANROOMS TO DRIVE MARKET
                    TABLE 27 MARKET FOR LIFE SCIENCES AND BIOTECHNOLOGY RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION)
    9.4 HOSPITALS AND HEALTHCARE FACILITIES 
           9.4.1 INCREASING NUMBER OF HOSPITAL-ACQUIRED INFECTIONS AND SURGICAL PROCEDURES TO DRIVE MARKET
                    TABLE 28 MARKET FOR HOSPITALS AND HEALTHCARE FACILITIES, BY REGION, 2021–2028 (USD MILLION)
 
10 BIO DECONTAMINATION MARKET, BY REGION (Page No. - 91)
     10.1 INTRODUCTION 
             TABLE 29 MARKET, BY REGION, 2021–2028 (USD MILLION)
     10.2 NORTH AMERICA 
             FIGURE 22 NORTH AMERICA: BIO DECONTAMINATION MARKET SNAPSHOT
             TABLE 30 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 31 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
             TABLE 32 NORTH AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 33 NORTH AMERICA: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
             TABLE 34 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Increasing number of surgical procedures to drive market
                                     TABLE 35 US: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                     TABLE 36 US: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                     TABLE 37 US: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
                                     TABLE 38 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Rising investments in healthcare to drive market
                                     TABLE 39 CANADA: BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                     TABLE 40 CANADA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                     TABLE 41 CANADA: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
                                     TABLE 42 CANADA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.3 NORTH AMERICA: RECESSION IMPACT
     10.3 EUROPE 
             TABLE 43 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 44 EUROPE: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
             TABLE 45 EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 46 EUROPE: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
             TABLE 47 EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Implementation of mandates associated with sterilization of healthcare equipment to drive market
                                     TABLE 48 GERMANY: BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                     TABLE 49 GERMANY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                     TABLE 50 GERMANY: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
                                     TABLE 51 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Increasing healthcare expenditure and implementation of regulatory guidelines to drive market
                                     TABLE 52 UK: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                     TABLE 53 UK: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                     TABLE 54 UK: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
                                     TABLE 55 UK: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Favorable government initiatives for adoption of sterilization services to drive market
                                     TABLE 56 FRANCE: BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                     TABLE 57 FRANCE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                     TABLE 58 FRANCE: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
                                     TABLE 59 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Rising growth in pharmaceutical & biotechnology industry to drive market
                                     TABLE 60 ITALY: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                     TABLE 61 ITALY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                     TABLE 62 ITALY: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
                                     TABLE 63 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Rising expansion of healthcare facilities to support market growth
                                     TABLE 64 SPAIN: BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                     TABLE 65 SPAIN: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                     TABLE 66 SPAIN: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
                                     TABLE 67 SPAIN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.6 REST OF EUROPE
                       TABLE 68 REST OF EUROPE: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                       TABLE 69 REST OF EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 70 REST OF EUROPE: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
                       TABLE 71 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.7 EUROPE: RECESSION IMPACT
     10.4 ASIA PACIFIC 
             FIGURE 23 ASIA PACIFIC: BIO DECONTAMINATION MARKET SNAPSHOT
             TABLE 72 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 73 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
             TABLE 74 ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 75 ASIA PACIFIC: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
             TABLE 76 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 High growth in pharmaceutical industry to drive market
                                     TABLE 77 JAPAN: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                     TABLE 78 JAPAN: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                     TABLE 79 JAPAN: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
                                     TABLE 80 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Increasing growth in medical device manufacturing industry to drive market
                                     TABLE 81 CHINA: BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                     TABLE 82 CHINA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                     TABLE 83 CHINA: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
                                     TABLE 84 CHINA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Establishment of key medical manufacturing companies to drive market
                                     TABLE 85 INDIA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                     TABLE 86 INDIA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                     TABLE 87 INDIA: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
                                     TABLE 88 INDIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                       TABLE 89 REST OF ASIA PACIFIC: BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                       TABLE 90 REST OF ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 91 REST OF ASIA PACIFIC: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
                       TABLE 92 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.5 ASIA PACIFIC: RECESSION IMPACT
     10.5 REST OF THE WORLD 
             TABLE 93 REST OF THE WORLD: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
             TABLE 94 REST OF THE WORLD: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 95 REST OF THE WORLD: MARKET, BY AGENT TYPE, 2021–2028 (USD MILLION)
             TABLE 96 REST OF THE WORLD: MARKET, BY END USER, 2021–2028 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 128)
     11.1 OVERVIEW 
     11.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             TABLE 97 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
     11.3 REVENUE SHARE ANALYSIS 
             FIGURE 24 BIO DECONTAMINATION MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS
     11.4 MARKET SHARE ANALYSIS 
             TABLE 98 MARKET: INTENSITY OF COMPETITIVE RIVALRY
     11.5 COMPANY EVALUATION MATRIX 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 25 MARKET: COMPANY EVALUATION MATRIX (GLOBAL)
     11.6 COMPANY EVALUATION MATRIX FOR SMES/STARTUPS 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                      FIGURE 26 MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS
     11.7 COMPANY FOOTPRINT ANALYSIS 
             TABLE 99 OVERALL FOOTPRINT OF COMPANIES
             TABLE 100 REGIONAL FOOTPRINT OF COMPANIES
             TABLE 101 PRODUCT FOOTPRINT OF COMPANIES
     11.8 COMPETITIVE BENCHMARKING 
             TABLE 102 BIO DECONTAMINATION MARKET: DETAILED LIST OF KEY SMES/STARTUPS
     11.9 COMPETITIVE SCENARIO 
             11.9.1 PRODUCT LAUNCHES AND APPROVALS
                       TABLE 103 KEY PRODUCT LAUNCHES AND APPROVALS (2020−2023)
             11.9.2 DEALS
                       TABLE 104 KEY DEALS (2020−2023)
             11.9.3 OTHER DEVELOPMENTS
                       TABLE 105 OTHER DEVELOPMENTS (2020−2023)
 
12 COMPANY PROFILES (Page No. - 140)
     12.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 STERIS PLC
                       TABLE 106 STERIS PLC: BUSINESS OVERVIEW
                       FIGURE 27 STERIS PLC: COMPANY SNAPSHOT (2022)
             12.1.2 ECOLAB
                       TABLE 107 ECOLAB: BUSINESS OVERVIEW
                       FIGURE 28 ECOLAB: COMPANY SNAPSHOT (2022)
             12.1.3 TOMI ENVIRONMENTAL SOLUTIONS, INC.
                       TABLE 108 TOMI ENVIRONMENTAL SOLUTIONS, INC.: BUSINESS OVERVIEW
                       FIGURE 29 TOMI ENVIRONMENTAL SOLUTIONS, INC.: COMPANY SNAPSHOT (2022)
             12.1.4 JCE BIOTECHNOLOGY
                       TABLE 109 JCE BIOTECHNOLOGY: BUSINESS OVERVIEW
             12.1.5 FEDEGARI AUTOCLAVI S.P.A
                       TABLE 110 FEDEGARI AUTOCLAVI S.P.A.: BUSINESS OVERVIEW
             12.1.6 ZHEJIANG TAILIN BIOENGINEERING CO., LTD.
                       TABLE 111 ZHEJIANG TAILIN BIOENGINEERING CO., LTD.: BUSINESS OVERVIEW
             12.1.7 HOWORTH AIR TECHNOLOGY LIMITED
                       TABLE 112 HOWORTH AIR TECHNOLOGY LIMITED: BUSINESS OVERVIEW
             12.1.8 SOLIDFOG TECHNOLOGIES
                       TABLE 113 SOLIDFOG TECHNOLOGIES: BUSINESS OVERVIEW
             12.1.9 CLORDISYS SOLUTIONS, INC.
                       TABLE 114 CLORDISYS SOLUTIONS, INC.: BUSINESS OVERVIEW
             12.1.10 AMIRA SRL
                       TABLE 115 AMIRA SRL: BUSINESS OVERVIEW
     12.2 OTHER PLAYERS 
             12.2.1 NOXILIZER, INC.
             12.2.2 TECOMAK
             12.2.3 DIOP GMBH & CO. KG
             12.2.4 AM INSTRUMENTS SRL
             12.2.5 ALLEN & COMPANY ENVIRONMENTAL SERVICES
             12.2.6 SYCHEM LIMITED
             12.2.7 CONTROLLED CONTAMINATION SERVICES
             12.2.8 KLENZAIDS
             12.2.9 CURIS DECONTAMINATION
             12.2.10 IHSS LTD.
             12.2.11 METALL+PLASTIC GMBH
             12.2.12 BIO DECONTAMINATION LTD.
             12.2.13 SYNTEGON TECHNOLOGY GMBH
             12.2.14 THE ECOSENSE COMPANY
             12.2.15 REATORG
             12.2.16 CLEAMIX
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 171)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

The study involved four major activities in estimating the current size of the bio decontamination market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Bio Decontamination Technicians/Technologists, Purchase Managers in Healthcare Provider Organizations, Bio-cleaning Specialists, Bio decontamination Supervisors) and supply sides (bio decontamination manufacturers and distributors).

The following is a breakdown of the primary respondents:

Breakdown of Primary Participants:

Bio Decontamination Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2. Tiers of companies are defined based on their total revenue. As of 2020: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the bio decontamination market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the bio decontamination industry.

Report Objectives

  • To define, describe, and forecast the global bio decontamination market based on products, services, region.
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, challenges, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3.
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the bio decontamination market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
  • Geographic Analysis:  Further breakdown of the European bio decontamination market into specific countries. 
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 7164
Published ON
Jun, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Bio Decontamination Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback